DOMENIC FLAMMIA: Open Payments
NPI 1487353223 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 69 payments from 22 companies in 2025. Trend: 2023 $498 · 2024 $794 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $305 |
| PFIZER INC. | 5 | $127 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| Exact Sciences Corporation | 5 | $104 |
| Novo Nordisk Inc | 4 | $99 |
| ABBVIE INC. | 3 | $99 |
| MILLICENT US INC | 4 | $88 |
| Sage Therapeutics, LLC | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
Products named: BREZTRI, AIRSUPRA, GARDASIL 9, Cologuard Collection Kit, ELIQUIS, ZURZUVAE, REXULTI, XIFAXAN.
Industry payments across CT — which companies pay providers there.
